Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial.

Eur J Pain. 2018 Aug;22(7):1321-1330. doi: 10.1002/ejp.1221. Epub 2018 Apr 18. Kerckhove N1,2, Pereira B1, Soriot-Thomas S3, Alchaar H4, Deleens R5, Hieng VS6, Serra E3, Lanteri-Minet M1,4, Arcagni P7, Picard P1, Lefebvre-Kuntz D8, Maindet C9, Mick G10, Balp L11, Lucas

Development of the First Two-Pore Domain Potassium Channel TWIK-Related K+ Channel 1-Selective Agonist Possessing in Vivo Antinociceptive Activity.

J Med Chem. 2017 Feb 9;60(3):1076-1088. doi: 10.1021/acs.jmedchem.6b01285. Epub 2017 Jan 20. Vivier D1, Soussia IB2, Rodrigues N1, Lolignier S3, Devilliers M3, Chatelain FC2, Prival L3, Chapuy E3, Bourdier G1, Bennis K1, Lesage F2, Eschalier A3,4, Busserolles J3, Ducki S1.

Analgesic effects of mambalgin peptide inhibitors of acid-sensing ion channels in inflammatory and neuropathic pain.

Pain. 2016 Mar;157(3):552-9. doi: 10.1097/j.pain.0000000000000397. Analgesic effects of mambalgin peptide inhibitors of acid-sensing ion channels in inflammatory and neuropathic pain. Diochot S1, Alloui A, Rodrigues P, Dauvois M, Friend V, Aissouni Y, Eschalier A, Lingueglia E, Baron A. Abstract Mambalgins